Supplementary Table from Clinical Outcomes and Immune Markers by Race in a Phase I/II Clinical Trial of Durvalumab Concomitant with Neoadjuvant Chemotherapy in Early-Stage TNBCJulia Foldi, Lajos Pusztai, Emily Reisenbichler et al.|Unknown|2023Cited by 0
Data from Clinical Outcomes and Immune Markers by Race in a Phase I/II Clinical Trial of Durvalumab Concomitant with Neoadjuvant Chemotherapy in Early-Stage TNBCJulia Foldi, Lajos Pusztai, Adriana Kahn et al.|Unknown|2023Cited by 0